96898 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
TIFA antagonists and their use for treating diseases
#1802Methods and compositions for targeting polyubiquitin
#1803Peptides and combination of peptides for use in immunotherapy against various tumors
#1804EPHA2 t-cell epitope agonists and uses therefore
#1805Budding yeast with human chromatin
#1806Peptide exhibiting hydrolytic activity and use thereof
#1807Compositions and methods for treating or ameliorating fibrosis, systemic sclerosis and scleroderma
#1808Methods of use of soluble CD24 for therapy of rheumatoid arthritis
#1809CD27L collectin fusion proteins and encoding nucleic acids
#1810Use of improved modulators of complement function as cancer therapeutics
#1811ENDOPLASMIC RETICULUM LOCALIZATION SIGNALS
#1812Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient
#1813DNA vaccine against virus of Yellow Fever
#1814Peptides and combination of peptides for use in immunotherapy against various cancers
#1815MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME
#1816Small mobile stem cells (SMS) and uses thereof
#1817NOVEL FUSION POLYPEPTIDE SPECIFIC FOR LAG-3 AND PD-1
#1818Apelin peptides and uses thereof
#1819Ubiquitin variants and uses therof as 53BP1 inhibitors
#1820Polypeptide expressed in the stratum corneum and use thereof
#1821Interleukin-13 binding proteins
#1822α-synuclein expression inhibitor
#1823Circular tandem repeat proteins
#1824Peptides and combination of peptides for use in immunotherapy against various tumors
#1825Triple glucagon/GLP-1/GIP receptor agonist
#1826Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders
#1827Methods for determining the risk of cardiovascular disease in a subject having a chronic viral infection through the measurement of lysophosphatidic acid
#1828KIDNEY-SPECIFIC TUMOR VACCINE DIRECTED AGAINST KIDNEY TUMOR ANTIGEN G-250
#1829Therapeutic DLL4 Binding Proteins
#1830NKG2D decoys
#1831NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN
#1832NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN
#1833SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF
#1834METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES
#1835Modulators of complement function
#1836Peptides and methods related to ICOS signaling
#1837Methods for detecting traumatic brain injury
#1838Sensors and assays for ubiquitin or ubiquitin-like proteins
#1839Targeted augmentation of nuclear gene output
#1840Single chain fusionconstructs comprising multimeric antibody fragments fused to collagen trimerization domains
#1841Method for preparing composition for promoting hair growth using Nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid
#1842Methods and compositions for genome engineering
#1843IMMUNOMODULATORY PROTEINS
#1844MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES
#1845Peptides and combination of peptides for use in immunotherapy against various cancers
#1846Peptides and combination of peptides for use in immunotherapy against various cancers
#1847Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival
#1848ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT
#1849Marker for pancreatic cancer and intraductal papillary mucinous neoplasms
#1850IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH
#1851Peptide, Complex of Peptide and siRNA, and Methods of Use Thereof
#1852Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
#1853SynP160, a promoter for the specific expression of genes in rod photoreceptors
#1854Ferritin nanoparticle compositions and methods to modulate cell activity
#1855Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1856Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1857Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1858Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1859MEANS AND METHODS FOR PREPARING ENGINEERED PROTEINS BY GENETIC CODE EXPANSION IN INSECT CELLS
#1860POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER
#1861Peptides and combination of peptides for use in immunotherapy against various tumors
#1862NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN
#1863SYNP162, a promoter for the specific expression of genes in rod photoreceptors
#1864Engineered light-activated anion channel proteins and methods of use thereof
#1865Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1866Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1867Peptides and combination of peptides for use in immunotherapy against various tumors
#1868METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM
#1869Methods and compositions for treating cancer
#1870Collagenase-derived peptides promote tissue regeneration and wound healing
#1871Methods to spatially profile protease activity in tissue and sections
#1872Artificial nucleases including engineered FokI cleavage half-domains
#1873METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#1874Compositions and methods for modulating kinase activity
#1875Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)
#1876Recombinant protein for preventing or treating tissue fibrosis and composition for preventing or treating tissue fibrosis comprising the same
#1877Electrically conductive protein nanofibers and biofilms
#1878In vitro assembly of bacterial microcompartments
#1879Rodents having a humanized gene
#1880Platelet biomarkers and diagnostic methods for vascular diseases
#1881NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#1882Peptides for the treatment of resorptive bone disease
#1883Composition for improving skin conditions comprising a fragment of human heat shock protein 90A as an active ingredient
#1884Peptides
#1885Targeting proteins for degradation
#1886Selenium-based therapies
#1887Polypeptide-polymer conjugates and methods of use thereof
#1888Immunoregulatory agent
#1889Soluble MANF in pancreatic beta-cell disorders
#1890CELL CULTURE MEDIUM AND CULTURE METHOD USING THE SAME
#1891ANTI-HLA ASSAY AND METHODS
#1892Auto-injector with signaling cap
#1893Compositions and methods for improving viral vector efficiency
#1894METHODS FOR TREATING MYELOPROLIFERATIVE DISORDERS
#1895METHODS AND COMPOSITIONS FOR INCREASING SMN EXPRESSION
#1896Methods and compositions for gene inactivation
#1897Biocatalysts for ezetimibe synthesis
#1898System comprising a nucleotide sequence encoding a volvox carteri light-activated ion channel protein (VCHR1)
#1899Modified Polynucleotides for the production of biologics and proteins associated with human disease
#1900Prostate-targeting adeno-associated virus serotype vectors
#1901Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#1902Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist
#1903METHODS FOR PREVENTING OR TREATING DISORDERS BY INCREASING BIOAVAILABILITY OF IRON AND RELATED PHARMACEUTICAL FORMULATION
#1904PRODUCTION OF FMDV-RESISTANT LIVESTOCK BY ALLELE SUBSTITUTION
#1905Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same
#1906Follistatin in treating duchenne muscular dystrophy
#1907Modified Tamm-Horsfall protein and related compositions and methods of use
#1908Polypeptides and antibodies to treat skin conditions associated with overproduction of sebum
#1909ENGINEERED INTEGRIN BINDING PEPTIDE COMPOSITIONS
#1910TPM4-ALK fusion protein and composition for diagnosing cancer
#1911SECRETED PROTEINS
#1912POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS
#1913Chimeric protein in the treatment of amyloidosis
#1914Cell lines for screening odorant and aroma receptors
#1915Treatment of cancer using chimeric antigen receptor and protein kinase a blocker
#1916Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
#1917Extracellular vesicles with enhanced potency
#1918Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#1919Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin
#1920Treatment targeting oncology and neurodegeneration
#1921Human-derived ferritin monomer fragment and fusion polypeptide using same
#1922Regulatory T cell epitopes, compositions and uses thereof
#1923Regulatory T cell epitopes, compositions and uses thereof
#1924Regulatory T cell epitopes, compositions and uses thereof
#1925Regulatory T cell epitopes, compositions and uses thereof
#1926Regulatory T cell epitopes, compositions and uses thereof
#1927Regulatory T cell epitopes, compositions and uses thereof
#1928Regulatory T cell epitopes, compositions and uses thereof
#1929Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics
#1930Neutralizing antibodies and methods of use thereof
#1931CD8a and t cell receptor variants and methods of using same in modulating immune cell responses
#1932Compounds and methods of treating usher syndrome III
#1933Modulation of proprotein convertase subtilisin/kexin 9 expression (PCSK9) with HSP 27 and/or HSP25
#1934Method for mass producing proteins in mesenchymal stem cells
#1935In vitro production of red blood cells with sortaggable proteins
#1936RASAL1 is a major tumor suppressor gene in thyroid cancer
#1937Multi-epitopic construct
#1938ERG targeted therapy
#1939Chimeric inhibitor molecules of complement activation
#1940Bone substitute nanocomposites and methods of synthesis using multiphosphorylated peptides
#1941Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
#1942Method for generating a humanized transgenic mouse comprising a human APRIL gene
#1943MECP2E1 gene
#1944MECP2E1 gene
#1945RNA preparations comprising purified modified RNA for reprogramming cells
#1946DNA molecules encoding antibodies to tau and methods of making thereof
#1947Combined Tissue Resonance Suppression Therapy and Autologous Polyvalent Biological Vaccine
#1948INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#1949Probes and assays for measuring E3 ligase activity
#1950RELAXIN1 derived peptides for use in immunotherapy against various tumors
#1951H3T3A mutant protein efficiently reduces H3T3P and causes increased cell death of rapidly dividing cells
#1952Target for treating hepatitis B virus
#1953Non-human animal models of retinoschisis
#1954Compositions and methods for improved neurotoxin assays
#1955COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#1956Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors
#1957Peptides and combination of peptides for use in immunotherapy against various tumors
#1958NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#1959MULTIMERIZATION TECHNOLOGIES
#1960COLON DISEASE TARGETS AND USES THEREOF
#1961Combination therapies for human papillomavirus-associated diseases comprising administration of therapeutic vaccine and recombinant virus vector
#1962Methods, compounds and compositions for modulating blood brain barrier integrity and re-myelination
#1963Monoclonal antibody for predicting tamoxifen response in breast cancer patients
#1964Antibody to human and mouse SEMA3A and use thereof
#1965Methods and compositions for altering function and structure of chromatin loops and/or domains
#1966NOVEL ANTIBODY AGAINST RIBOSOMAL PROTEIN S3 AND COMPOSITION FOR DIAGNOSING BIOLOGICAL STRESS
#1967Opsin polypeptides and methods of use thereof
#1968Extended recombinant polypeptides and compositions comprising same
#1969Compositions and methods of use for recombinant human secretoglobins
#1970Multiplex biomarker for use in evaluation of state of accumulation of amyloid B in brain, and analysis method for said evaluation
#1971Bi-specific fusion proteins
#1972Peptides and combination of peptides for use in immunotherapy against various tumors
#1973Peptides and combination of peptides for use in immunotherapy against various tumors
#1974Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereof
#1975Compositions and methods for vascular protection against reperfusion injury after myocardial ischemia
#1976Fusion protein or conjugated protein, intracellular delivery carrier, partial peptide, cell membrane permeation enhancer, DNA, and vector
#1977Heterocyclic compound
#1978AMELOGENIN-CHITOSAN HYDROGEL FOR DENTIN HYPERSENSITIVITY
#1979Isoform Nell-1 peptide
#1980SH3 domain derivatives
#1981POLYPEPTIDES
#1982INHIBITION OF THE COMPLEMENT SYSTEM
#1983Peptides and combination of peptides for use in immunotherapy against various tumors
#1984Peptides and combination of peptides for use in immunotherapy against various tumors
#1985Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
#1986Methods for measuring small molecule affinity to cereblon
#1987ANTIBODY THAT BINDS MURINE WISE PROTEIN
#1988Tumor-selective CTLA-4 antagonists
#1989Dominant positive hnRNP-E1 polypeptide compositions and methods
#1990PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY
#1991Methods and reagents for diagnosing Sjögren's Syndrome
#1992MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS
#1993Peptides and combination of peptides for use in immunotherapy against various tumors
#1994Peptides and combination of peptides for use in immunotherapy against various tumors
#1995Process for the coupled production of sweet whey and lactic acid from acid whey
#1996B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE
#1997LIGHT-ACTIVATED, CALCIUM-GATED POLYPEPTIDE AND METHODS OF USE THEREOF
#1998Process for producing an allergen extract
#1999Process for Producing an Allergen Extract
#2000Immune inducer
#2001Methods and compositions for treating trinucleotide repeat disorders
#2002BONE MARROW STROMAL CELL DERIVED EXTRACELLULAR MATRIX PROTEIN EXTRACT AND USES THEREOF
#2003Compositions and methods for determining genetic polymorphisms in the TMEM216 gene
#2004Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#2005Engineered endothelial cells expressing an ETS transcription factor
#2006Peptides and compositions for treatment of joint damage
#2007Binding proteins based on di-ubiquitin muteins and methods for generation
#2008Chlorotoxin variants, conjugates, and methods for their use
#2009Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
#2010Tunable endogenous protein degradation
#2011DIAGNOSTIC TARGET
#2012BIN1 expression as a marker of cancer
#2013DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES
#2014MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
#2015Cryptic polypeptides and uses thereof
#2016CRISPR-based methods and products for increasing frataxin levels and uses thereof
#2017Recombinant polypeptide for enhancing cell transduction efficiency of a target agent
#2018Viral chimeric particle of potato virus X and use thereof for in vitro diagnosis of Sjögren syndrome
#2019Peptide having antimicrobial activity against pathogens and antimicrobial peptide composition comprising the same
#2020Methods of delivery of transgenes for treating brain diseases
#2021Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein
#2022Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses
#2023CELLULAR EXPRESSION MODEL OF TAU AGGREGATION
#2024Slit2D2-HSA fusion protein and use thereof against tumours
#2025Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
#2026Adiponectin peptidomimetics for treating ocular disorders
#2027CANCER TARGETS AND USES THEREOF
#2028IL-31 ANTIBODY COMPOSITIONS
#2029VEGF antagonist formulations suitable for intravitreal administration
#2030HISTONE ANTI-CANCER VACCINES
#2031Recombinant binding proteins targeting HER2 and serum albumin, and their uses
#2032Synergistic combination of neuronal viability factors and uses thereof
#2033Application and uses of PRG4 and therapeutic modulation thereof
#2034Dispersion and detachment of cell aggregates
#2035Compounds and methods for increasing antisense activity
#2036SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS
#2037Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases
#2038Toll-like receptor 4 (TLR4) antagonist
#2039Anti-cancer fusion polypeptides, encoding nucleic acids and methods of using polypeptides
#2040Proteins specific for CD137
#2041Inhibitors of mitochondrial fission and methods of use thereof
#2042Methods and compositions for the treatment of cancer or other diseases
#2043ANTIBODY PRODUCING NON-HUMAN ANIMALS
#2044ANTIBODY PRODUCING NON-HUMAN ANIMALS
#2045Antibody producing non-human animals
#2046ANTIBODY PRODUCING NON-HUMAN ANIMALS
#2047Antibody producing non-human animals
#2048Peptides and combination of peptides for use in immunotherapy against various tumors
#2049Anti-tumor peptides and use thereof
#2050Frataxin expression constructs
#2051Propionyl-CoA carboxylase compositions and uses thereof
#2052Method for detecting and measuring endogenous complexes as a new tumour marker
#2053Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM/MRM Assay
#2054METHODS FOR DIAGNOSING DISEASES ASSOCIATED WITH HUMAN SIGNAL PEPTIDE-CONTAINING MOLECULES
#2055MEMBRANE-RECEIVER COMPLEX THERAPEUTICS
#2056Antibody producing non-human animals
#2057Stabilized STAT3 decoy oligonucleotides and uses therefor
#2058Porous protein particles as carriers for actives
#2059Targeting macula densa cells as a new therapeutic approach for kidney disease
#2060Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#2061Modified binding proteins inhibiting the VEGF-A receptor interaction
#2062RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS
#2063Therapeutic peptides for cerebrovascular diseases
#2064Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
#2065Transgenic mouse model for dementia
#2066Modified cascade ribonucleoproteins and uses thereof
#2067Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer
#2068COMPOSITIONS COMPRISING RECEPTOR-ASSOCIATED PROTEIN (RAP) VARIANTS SPECIFIC FOR CR-CONTAINING PROTEINS AND USES THEREOF
#2069USE OF IMMUNESUPPRESSANT RECEPTOR
#2070Method for producing protein
#2071CDCA1 epitope peptides for Th1 cells and vaccines containing the same
#2072COMPOSITIONS AND METHODS FOR GENERATING ANTIGENS, ANTIBODIES, AND IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS
#2073Protein purification by anion exchange chromatography
#2074TAFA4 COMPOUNDS AND USES THEREOF FOR TREATING PAIN
#2075METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#2076Immune modulator for immunotherapy and vaccine formulation
#2077Oxidative modification improves the drugability of cell penetrating peptides as drug carriers
#2078Peptides and combination of peptides for use in immunotherapy against various tumors
#2079BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF
#2080De novo engineering of site-specific molecules by tethering
#2081Necroptosis Signaling as a Therapeutic Target for Alzheimer's Disease
#2082Peptides and combination of peptides for use in immunotherapy against various tumors
#2083Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the same
#2084Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
#2085Compositions and methods for modulating an immune response
#2086PROTEIN EXPRESSION ENHANCING POLYPEPTIDES
#2087Materials and methods for extended continuous flow fermentation of reduced genome bacteria
#2088METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#2089MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#2090Proteins specific for pyoverdine and pyochelin
#2091IMMUNOMODULATORY PROTEINS
#2092Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof
#2093Polypeptides binding to human complement C5
#2094TRPV3 agonists for the treatment of skin conditions
#2095Viral vectors for the treatment of retinal dystrophy
#2096Methods and compositions employing immunogenic fusion proteins
#2097Adiponectin peptidomimetics for treating ocular disorders
#2098Hybrid protein for the identification of neddylated substrates
#2099Homologous recombination factors
#2100Recombinant protein-based method for the delivery of silencer RNA to target the brain